Overview

Oxytocin Treatment of Alcohol Dependence

Status:
Completed

Trial end date:
2014-03-01

Target enrollment:

Participant gender:

Summary

This study will test in individuals who have alcohol dependence (alcohol addiction) the hypotheses 1) that intranasal oxytocin treatment will decrease withdrawal symptoms during medical detoxification and 2) that intranasal oxytocin treatment for 12 weeks in the outpatient setting will decrease drinking.

Phase:

Phase 2

Details

Lead Sponsor:

University of North Carolina, Chapel Hill

Treatments:

Ethanol
Oxytocin